Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3A
|
pubmed:dateCreated |
1992-4-23
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
8750-2836
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
130-4
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1548323-Antihypertensive Agents,
pubmed-meshheading:1548323-Coronary Disease,
pubmed-meshheading:1548323-Glucose,
pubmed-meshheading:1548323-Humans,
pubmed-meshheading:1548323-Insulin,
pubmed-meshheading:1548323-Insulin Resistance,
pubmed-meshheading:1548323-Lipoproteins,
pubmed-meshheading:1548323-Risk Factors
|
pubmed:year |
1992
|
pubmed:articleTitle |
Insulin resistance and coronary artery disease.
|
pubmed:affiliation |
University of Texas, Galveston.
|
pubmed:publicationType |
Journal Article
|